WHO ICTRP trial
A diagnostic test for Human papillomavirus genotyping (23 types) detection kit…
ChiCTR1800020027 · Chinese Clinical Trial Registry (ChiCTR) · Recruiting
Key facts
| Trial ID | ChiCTR1800020027 |
|---|---|
| Public title | A diagnostic test for Human papillomavirus genotyping (23 types) detection kit (PCR-reverse dot blot method) |
| Scientific title | A diagnostic test for Human papillomavirus genotyping (23 types) detection kit (PCR-reverse dot blot method) |
| Primary sponsor | Yaneng Biotechnology (Shenzhen) Co., Ltd. |
| Registry | Chinese Clinical Trial Registry (ChiCTR) |
| Recruitment status | Recruiting |
| Study type | Diagnostic test |
| Phase | Diagnostic New Technique Clincal Study |
| Countries | China |
| Conditions | cervical lesion |
| Interventions | Gold Standard:1. Detection of human papillomavirus infection by sequencing; 2. Cervical pathology results as the gold standard.;Index test:Human papillomavirus genotyping (23 types) detection kit (PCR-reverse dot blot method) |
| Registration date | Dec 12, 2018 |
| Target size | Target condition:900;Difficult condition:150 |
| Registry page | chictr.org.cn |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: